Chelsea joined Alira Health in 2018 after the acquisition of Clinical Assistance Programs (CAP), a specialty CRO. Chelsea has held several roles at CAP and Alira Health, managing Phase I, II, and III clinical trials. She provides trial oversight and guidance including management of vendors and in-house teams, as well as providing study details and timelines, and ensuring collaboration between all functional groups. Chelsea received her Bachelor of Science degree in Biology from Tufts University.
View in org chart
View in org chart
Current role
Director, Clinical Operations at Arrivo BioVentures
Director, Clinical Operations at Kedalion Therapeutics
Director, Clinical Operations at Excision BioTherapeutics
Director, Clinical Operations at Immunexpress
Director, Clinical Operations at Acumen Pharmaceuticals